[Leu14]bombesin [4684]



[Leu14]bombesin


SMILES CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCC(=O)N1)C(C)C)C(N)=O
InChIKey SVVDBCGUBZWHSS-FPFNSDSHSA-N
Sequence XQRLGNQWAVGHLL
HELM PEPTIDE1{[Glp].Q.R.L.G.N.Q.W.A.V.G.H.L.L.[am]}$$$$

Chemical Properties

Hydrogen bond acceptors 20
Hydrogen bond donors 23
Rotatable bonds 50
Log P -6.511
Molecular weight (Da) 1600.9
Stereochemistry info unspecified

Database connections

Model (AF2) BB2

Bioactivities

Receptor Activity Source
Protein Gene Species Family Class Type Min Avg Max Database
Receptor Activity Source
Protein Gene Species Family Class Type Min Avg Max Database

[Leu14]bombesin


Drug properties

Molecular type Peptide
Physiological/Surrogate Surrogate
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections

Model (AF2) BB2

Compound is not listed as a drug.